Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
about
Metabolic actions of metformin in the heart can occur by AMPK-independent mechanismsA pharmacological activator of AMP-activated protein kinase (AMPK) induces astrocyte stellation.AMPK in the brain: its roles in energy balance and neuroprotectionNeuropharmacological Actions of Metformin in StrokeStructural basis for compound C inhibition of the human AMP-activated protein kinase α2 subunit kinase domainA dual role for AMP-activated protein kinase (AMPK) during neonatal hypoxic-ischaemic brain injury in miceEffects of AMP-activated protein kinase in cerebral ischemiaMetabolic regulation of neuronal plasticity by the energy sensor AMPKShizukaol D isolated from Chloranthus japonicas inhibits AMPK-dependent lipid content in hepatic cells by inducing mitochondrial dysfunctionLipopolysaccharide-induced loss of cultured rat myenteric neurons - role of AMP-activated protein kinaseHydrogen peroxide induces expression and activation of AMP-activated protein kinase in a dental pulp cell lineEmerging therapeutic interventions against noise-induced hearing loss.Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses.Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase.Imaging brain activation: simple pictures of complex biology.Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model.Caloric restriction stimulates revascularization in response to ischemia via adiponectin-mediated activation of endothelial nitric-oxide synthaseAICAR activates the pluripotency transcriptional network in embryonic stem cells and induces KLF4 and KLF2 expression in fibroblasts.Neuroglobin Overexpression Inhibits AMPK Signaling and Promotes Cell Anabolism.Disruption of the axon initial segment cytoskeleton is a new mechanism for neuronal injury.Fenofibrate promotes ischemia-induced revascularization through the adiponectin-dependent pathway.Targeting protein kinases in central nervous system disordersActivation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's diseaseDifferential mechanisms underlying neuroprotection of hydrogen sulfide donors against oxidative stress.Epigenetics and the environment: in search of the "toleroasome" vital to execution of ischemic preconditioning.To Use or Not to Use Metformin in Cerebral Ischemia: A Review of the Application of Metformin in Stroke RodentsAMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis.Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin.Role of the energy sensor AMP-activated protein kinase in renal physiology and diseaseAcute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy.Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.Expression of Na-K-Cl cotransporter and edema formation are age dependent after ischemic stroke.Adenosine monophosphate activated protein kinase inhibition is protective in both sexes after experimental stroke.Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.The outcome of renal ischemia-reperfusion injury is unchanged in AMPK-β1 deficient mice.The microtubule-associated protein EB1 links AIM2 inflammasomes with autophagy-dependent secretion.Increased RhoA prenylation in the loechrig (loe) mutant leads to progressive neurodegenerationMiddle cerebral artery occlusion model in rodents: methods and potential pitfalls.AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.Susceptibility to ATP depletion of primary proximal tubular cell cultures derived from mice lacking either the α1 or the α2 isoform of the catalytic domain of AMPK.
P2860
Q22241963-40C065B3-439F-44E6-A6CD-19B0249C3044Q24564748-AFBE6DB3-E561-4D60-8A5A-09AFDAFF195EQ24629417-1C2A3CBD-43BD-4136-B6A5-16F11CE58B52Q26786307-80032759-3F9D-484B-8E87-93B73BCA5418Q27667722-721FA48A-CA53-4764-959F-4A08A933573CQ28393673-07A9B7AB-F2CD-4463-BA00-4869110C4E2BQ28394686-161EFE2D-DDEB-453A-8C3A-6390E4EC5D8AQ28472728-4FA7EFCC-541B-4C1F-9781-300070F1987AQ28535328-BFEB5B38-5F0E-4B99-AEC8-B6DBF25B3483Q28542433-73E9FD21-A56B-4322-9CAA-6290EB65DF45Q28569956-35AFC1CA-C0BD-49BE-8B28-45632D8C653BQ30240239-F5B2810B-3377-44D4-9FC0-C1A5C532FB55Q30279123-41104843-9C3F-4540-A0E8-8FF6C782EAEEQ30441622-CAC0CFBC-0DE4-4D1A-9D25-CAA63225BC3FQ30484843-515EC633-F26D-4D12-9E38-EB2AAB8D7086Q30548210-0CEC7860-66CA-4E0A-8742-98592E0F939EQ30850845-CF5D3439-184C-450B-A818-C7B5EC131A22Q33409118-6D256492-8807-46C0-B760-46F30A3A8721Q33569757-C86D282A-3B0E-4F2C-BE50-644780B1D1BDQ33570384-F1D9280D-B0B4-4A5F-BF57-C932880CE1CFQ33642616-6C2759F1-76F6-49B8-B660-0199F46FDDC4Q33671660-BD49E392-D61B-41CF-AC63-A65F89709403Q33690517-EDAD9561-0F10-4CF2-BC21-6F81C4202C22Q33692977-4C977AF8-700D-41E1-84C7-A4A884EA2B7EQ33693885-EF4600CA-3730-4B5D-8503-B8276CEFECD4Q33787067-C0C0ACA7-DE9D-4EF5-9766-11E28F4B6409Q33788455-98FAE2F0-70ED-4E83-90ED-2600C7D4A42AQ33832521-8FCF7736-07D9-4910-BEC2-3D26214514F6Q33840570-7B6A4237-08AF-4052-8B46-B1F41B5ED532Q33842696-233DC187-6E91-47D8-920E-E8064305A402Q33912715-FE42FF5B-D5F8-4CCA-B966-553B718DE34CQ34005627-B3A76A90-D378-4D29-A96D-AE5AC23159E5Q34118392-E434053D-D510-4396-AB95-7CCE9A0EB8DEQ34123865-F222F4B3-A141-4308-A8D0-8DDCCEEB7157Q34130765-D316BB4A-BCE5-44A1-95A1-90C6102F1D21Q34355815-68BC4BC1-058D-406B-9808-8D190B3D7FFFQ34412406-03734443-AE79-45C9-AA29-C694D94B3DA8Q34558344-5C80F1B1-970A-43DC-A13C-56B8CCB7CE18Q34696305-E077ED4C-4452-49C8-A6B1-203770BE8FB4Q35042551-2C301341-5E87-4C35-B010-F1C25998AAEE
P2860
Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacological inhibition of ...... ides neuroprotection in stroke
@ast
Pharmacological inhibition of ...... ides neuroprotection in stroke
@en
Pharmacological inhibition of ...... ides neuroprotection in stroke
@nl
type
label
Pharmacological inhibition of ...... ides neuroprotection in stroke
@ast
Pharmacological inhibition of ...... ides neuroprotection in stroke
@en
Pharmacological inhibition of ...... ides neuroprotection in stroke
@nl
prefLabel
Pharmacological inhibition of ...... ides neuroprotection in stroke
@ast
Pharmacological inhibition of ...... ides neuroprotection in stroke
@en
Pharmacological inhibition of ...... ides neuroprotection in stroke
@nl
P2093
P3181
P356
P1476
Pharmacological inhibition of ...... ides neuroprotection in stroke
@en
P2093
Gabriele V Ronnett
Jill McFadden
Leslie E Landree
Louise D McCullough
Zhiyuan Zeng
P304
P3181
P356
10.1074/JBC.M409985200
P407
P577
2005-05-27T00:00:00Z